Bardy Diagnostics is based in New Providence, NJ. It has raised $375M in total funding. Latest round: Series B.
Bardy Diagnostics is based in New Providence, NJ. Bardy Diagnostics has raised $375M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in April 2019. The round record for Bardy Diagnostics runs through 2019; nothing later has been disclosed. Investors on record include River Cities Capital Funds, HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures, Rex Health Ventures and 3 others. 9 distinct backers are named across the disclosed rounds.
Totals shown for Bardy Diagnostics aggregate every disclosed round on file. To see how that compares, browse the companies in New Providence and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026